These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9183815)
1. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux. Byrnes EM; Reilly A; Bruno JP Synapse; 1997 Jul; 26(3):254-68. PubMed ID: 9183815 [TBL] [Abstract][Full Text] [Related]
2. Modulation of GABA release by dopamine in the substantia nigra. Matuszewich L; Yamamoto BK Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635 [TBL] [Abstract][Full Text] [Related]
3. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies. Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355 [TBL] [Abstract][Full Text] [Related]
4. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708 [TBL] [Abstract][Full Text] [Related]
5. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels. Mela F; Marti M; Bido S; Cenci MA; Morari M Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605 [TBL] [Abstract][Full Text] [Related]
6. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata. Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750 [TBL] [Abstract][Full Text] [Related]
7. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Zackheim JA; Abercrombie ED Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986 [TBL] [Abstract][Full Text] [Related]
8. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways. Fantin M; Marti M; Auberson YP; Morari M J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236 [TBL] [Abstract][Full Text] [Related]
9. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. Abercrombie ED; DeBoer P J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422 [TBL] [Abstract][Full Text] [Related]
11. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ; Marshall JF Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899 [TBL] [Abstract][Full Text] [Related]
12. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. Hossain MA; Weiner N J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556 [TBL] [Abstract][Full Text] [Related]
14. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. Yamamoto BK; Nash JF; Gudelsky GA J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076 [TBL] [Abstract][Full Text] [Related]
15. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats. Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082 [TBL] [Abstract][Full Text] [Related]
16. Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism. Krolewski DM; Bishop C; Walker PD Synapse; 2005 Jul; 57(1):1-7. PubMed ID: 15858838 [TBL] [Abstract][Full Text] [Related]
17. Dopamine and GABA increases produced by activation of glutamate receptors in the nucleus accumbens are decreased during aging. Segovia G; Mora F Neurobiol Aging; 2005 Jan; 26(1):91-101. PubMed ID: 15585349 [TBL] [Abstract][Full Text] [Related]
18. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences. Harsing LG; Zigmond MJ Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. Grobin AC; Deutch AY J Pharmacol Exp Ther; 1998 Apr; 285(1):350-7. PubMed ID: 9536031 [TBL] [Abstract][Full Text] [Related]
20. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies. Abarca J; Gysling K; Roth RH; Bustos G Neurochem Res; 1995 Feb; 20(2):159-69. PubMed ID: 7783840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]